Last Price
0.79
Today's Change
+0.285 (56.43%)
Day's Change
0.56 - 1.56
Trading Volume
83,642,987
Profile
QNRX
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Michael Myers Ph.D. Dr. Michael Myers Ph.D.
Full Time Employees: 4 4
IPO Date: 2016-08-01 2016-08-01
CIK: 0001671502 0001671502
ISIN: US74907L3006 US74907L3006
CUSIP: 74907L102 74907L102
Beta: 2.03 2.03
Last Dividend: 0.00 0.00
Dcf Diff: -1.15 -1.15
Dcf: 2.66 2.66
Description
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
3
4
CEO Morning Brief
Nvidia Rides Fierce Blackwell Demand Towards Stock Record Again
5
CEO Morning Brief
Emirates Blasts Boeing for Delays, Plans ‘serious Conversations’
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
